Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dotta

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Clinical Immunology (Orlando, Fla.)|December 31, 2003
Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependentC Tiberti, F Bao, M Bonamico, et al.
The Journal of Experimental Medicine|July 11, 1992
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetesL S Wicker, M C Appel, F Dotta, et al.
Diabetes|November 1, 1989
Ganglioside expression in human pancreatic isletsF Dotta, P G Colman, D Lombardi, et al.
European Journal of Endocrinology|September 4, 1999
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitusF Dotta, S Dionisi, V Viglietta, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokinesL Marselli, F Dotta, S Piro, et al.
Diabetologia|April 7, 2010
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetesM Igoillo-Esteve, L Marselli, D A Cunha, et al.
Cytokine|February 6, 2021
Prognostic bioindicators in severe COVID-19 patientsL Bergantini, E Bargagli, M d'Alessandro, et al.
Diabetologia|June 30, 2005
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouseF Calcinaro, S Dionisi, M Marinaro, et al.
Clinical and Experimental Immunology|September 8, 2010
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humansA Olivieri, S De Angelis, S Dionisi, et al.
Diabetologia|September 12, 2012
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic isletsP Marchetti, R Lupi, M Bugliani, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|December 31, 2003
Celiac disease-associated transglutaminase autoantibody target domains at diagnosis are age and sex dependentC Tiberti, F Bao, M Bonamico, et al.
The Journal of Experimental Medicine|July 11, 1992
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetesL S Wicker, M C Appel, F Dotta, et al.
Diabetes|November 1, 1989
Ganglioside expression in human pancreatic isletsF Dotta, P G Colman, D Lombardi, et al.
European Journal of Endocrinology|September 4, 1999
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitusF Dotta, S Dionisi, V Viglietta, et al.
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokinesL Marselli, F Dotta, S Piro, et al.
Diabetologia|April 7, 2010
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetesM Igoillo-Esteve, L Marselli, D A Cunha, et al.
Cytokine|February 6, 2021
Prognostic bioindicators in severe COVID-19 patientsL Bergantini, E Bargagli, M d'Alessandro, et al.
Diabetologia|June 30, 2005
Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouseF Calcinaro, S Dionisi, M Marinaro, et al.
Clinical and Experimental Immunology|September 8, 2010
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humansA Olivieri, S De Angelis, S Dionisi, et al.
Diabetologia|September 12, 2012
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic isletsP Marchetti, R Lupi, M Bugliani, et al.
Pageof 9